Arrhythmia
Conditions
Interventions
A new venous disclosure system.
Figure eight suture hemostasis.
Sponsors
Tokyo Medical and Dental University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have undergone cardiac catheter ablation using sheaths with an inner diameter ranging from 6-12 French (maximum outer diameter of 15 French), and who are 20 years of age or older and capable of providing informed consent in writing.
Exclusion criteria
Exclusion criteria: History of previous use of femoral vein hemostasis device (leaving permanent sutures or metal clips). History of allergy to bovine-derived components. History of femoral vein stent placement. If physicians deem the case inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to ambulation (time from sheath removal to the initiation of walking without rebleeding). Time to hemostasis (time from sheath removal until hemostasis is achieved even with manual pressure discontinued). Procedural success rate (successful achievement of ambulation at the scheduled time per patient without complications). | — |
Countries
Japan
Contacts
Public ContactKentaro Goto
Tokyo Medical and Dental University Hospital Department of Cardiovascular Medicine, Advanced Arrhythmia Research.
Outcome results
None listed